SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-045305
Filing Date
2024-02-26
Accepted
2024-02-26 07:04:22
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d783925d424b5.htm 424B5 447689
2 EX-FILING FEES d783925dexfilingfees.htm EX-FILING FEES 45966
3 GRAPHIC g783925g04g04.jpg GRAPHIC 27477
4 GRAPHIC g783925g28d23.jpg GRAPHIC 28593
5 GRAPHIC g783925g49w19.jpg GRAPHIC 40707
  Complete submission text file 0001193125-24-045305.txt   625330
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275740 | Film No.: 24673515
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)